Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX7MLT
|
||||
Drug Name |
tert-butyl 1-(((S)-1-(5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)-1-oxopentan-2-yl)carbamoyl)cyclohexylcarbamate
|
||||
Synonyms |
CHEMBL209216
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H32N4O6
|
||||
Canonical SMILES |
CCC[C@H](NC(=O)C1(CCCCC1)NC(=O)OC(C)(C)C)C(=O)c2oc(nn2)c3occc3
|
||||
InChI |
InChI=1S/C23H32N4O6/c1-5-10-15(17(28)19-27-26-18(32-19)16-11-9-14-31-16)24-20(29)23(12-7-6-8-13-23)25-21(30)33-22(2,3)4/h9,11,14-15H,5-8,10,12-13H2,1-4H3,(H,24,29)(H,25,30)/t15-/m0/s1
|
||||
InChIKey |
CMCVBOBNUPQRNQ-HNNXBMFYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.